Cytori Therapeutics, Inc. Receives $1.5 Million Payment For The Option Granted To Olympus Corporation To Negotiate A Therapeutic Commercialization Collaboration

SAN DIEGO--(BUSINESS WIRE)--April 26, 2006--Cytori Therapeutics, Inc. (NASDAQ:CYTX - News; Frankfurt:XMPA - News) announced today it has received a $1.5 million payment for the option it granted to Olympus Corporation for the exclusive right to negotiate an adipose-derived stem and regenerative cell commercialization collaboration. The collaboration would include distribution rights to the Celution(TM) System and related one-time use cartridges for a specific therapeutic area outside of cardiovascular disease.